Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Elected officials are looking to expand access to weight loss drugs like Ozempic and Wegovy for low-income Virginians as part ...

Their symptom improvement was likely thanks to their weight loss, the FDA said. Zepbound is a glucagon-like peptide 1 drug that reduces appetite and food intake. The drug's active ingredient, ...

Body mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...